DERMATOP EMOLLIENT CREAM DIN 02230642
Health Canada record
| Active ingredient(s) | PREDNICARBATE 0.1 % |
|---|---|
| Dosage form | Cream |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | D07AC18 PREDNICARBATE |
| Original market date | 21-Mar-2001 |
| Current status date | 03-Dec-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bausch Health Companies Inc. — licence 101880, currently licensed, last inspection rating C (2026-06-01).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PREDNICARBATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02227517 | DERMATOP OINTMENT | BAUSCH HEALTH, CANADA INC. | Ointment | PREDNICARBATE 0.1 % | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 13072 | 2012-03-05 | New Drug Submission (NDS) | Manufacturer name change |
| 8030 | 2006-06-15 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 1383 | 2000-10-24 | New Drug Submission (NDS) | |
| 4036 | 1997-02-06 | Supplement to a New Drug Submission (SNDS) | NEW DOSAGE FORM, NEW INDICATION (PEDIATRIC USE) |
International API supply for PREDNICARBATE
3 valid EDQM Certificates of Suitability from 3 holders. 2 active FDA Drug Master Files.
Request a quote for DERMATOP EMOLLIENT CREAM